NLSP
Price
$2.28
Change
-$0.11 (-4.60%)
Updated
Jun 13 closing price
Capitalization
10.28M
SCNI
Price
$2.22
Change
-$0.11 (-4.72%)
Updated
Jun 13 closing price
Capitalization
2.22M
Interact to see
Advertisement

NLSP vs SCNI

Header iconNLSP vs SCNI Comparison
Open Charts NLSP vs SCNIBanner chart's image
Nls Pharmaceutics
Price$2.28
Change-$0.11 (-4.60%)
Volume$152.29K
Capitalization10.28M
Scinai Immunotherapeutics
Price$2.22
Change-$0.11 (-4.72%)
Volume$55.28K
Capitalization2.22M
NLSP vs SCNI Comparison Chart
Loading...
NLSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NLSP vs. SCNI commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NLSP is a StrongBuy and SCNI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (NLSP: $2.28 vs. SCNI: $2.22)
Brand notoriety: NLSP and SCNI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NLSP: 52% vs. SCNI: 11%
Market capitalization -- NLSP: $10.28M vs. SCNI: $2.22M
NLSP [@Biotechnology] is valued at $10.28M. SCNI’s [@Biotechnology] market capitalization is $2.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $356.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NLSP’s FA Score shows that 0 FA rating(s) are green whileSCNI’s FA Score has 2 green FA rating(s).

  • NLSP’s FA Score: 0 green, 5 red.
  • SCNI’s FA Score: 2 green, 3 red.
According to our system of comparison, both NLSP and SCNI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NLSP’s TA Score shows that 2 TA indicator(s) are bullish while SCNI’s TA Score has 2 bullish TA indicator(s).

  • NLSP’s TA Score: 2 bullish, 4 bearish.
  • SCNI’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, NLSP is a better buy in the short-term than SCNI.

Price Growth

NLSP (@Biotechnology) experienced а -0.87% price change this week, while SCNI (@Biotechnology) price change was -12.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NLSP($10.3M) has a higher market cap than SCNI($2.22M). NLSP YTD gains are higher at: 8.057 vs. SCNI (-33.632). SCNI has less debt than NLSP: SCNI (1.23M) vs NLSP (1.63M).
NLSPSCNINLSP / SCNI
Capitalization10.3M2.22M464%
EBITDAN/A7.8M-
Gain YTD8.057-33.632-24%
P/E RatioN/A1.19-
RevenueN/A452K-
Total CashN/A1.03M-
Total Debt1.63M1.23M133%
FUNDAMENTALS RATINGS
SCNI: Fundamental Ratings
SCNI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
8
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NLSPSCNI
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 19 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
NLSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYCN3.110.01
+0.43%
Cyclerion Therapeutics
LB72.50-0.58
-0.79%
LandBridge Company LLC
ULBI7.74-0.09
-1.15%
Ultralife Corp
KIDS21.16-0.56
-2.58%
OrthoPediatrics Corp
BOOT157.27-5.88
-3.60%
Boot Barn Holdings

NLSP and

Correlation & Price change

A.I.dvisor tells us that NLSP and MBIO have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NLSP and MBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NLSP
1D Price
Change %
NLSP100%
-4.60%
MBIO - NLSP
27%
Poorly correlated
-7.87%
SCNI - NLSP
26%
Poorly correlated
-4.72%
GOVX - NLSP
25%
Poorly correlated
-9.65%
FULC - NLSP
24%
Poorly correlated
+1.03%
SLRX - NLSP
24%
Poorly correlated
-7.03%
More

SCNI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNI has been closely correlated with WINT. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCNI jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
-4.72%
WINT - SCNI
89%
Closely correlated
-1.99%
NBY - SCNI
88%
Closely correlated
-6.77%
NCNA - SCNI
88%
Closely correlated
-24.41%
SNPX - SCNI
88%
Closely correlated
-23.66%
RNAC - SCNI
86%
Closely correlated
+1.76%
More